Literature DB >> 9120120

Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation.

F Stéphan1, D Méharzi, S Ricci, A Fajac, F Clergue, J F Bernaudin.   

Abstract

OBJECTIVE: The study was undertaken to determine if critically ill patients under mechanical ventilation could reactivate latent cytomegalovirus (CMV) in either lung or blood.
DESIGN: Prospective study in critically ill patients was performed in a multidisciplinary intensive care unit in a university hospital. PATIENTS: 23 non-immunocompromised, mechanically ventilated patients who were anti-CMV immunoglobulin G-positive. Ten immunocompromised patients with active CMV infection and 16 asymptomatic CMV seropositive non-immunocompromised patients constituted the positive and negative control groups. MEASUREMENTS AND
RESULTS: The presence of CMV in blood and bronchoalveolar lavage (BAL) was evaluated by both viral cultures and polymerase chain reaction (PCR). Thirty-seven blood and 22 BAL samples were investigated. Sequential samples were evaluated in 8 patients. For PCR, a 290 bp fragment in the first exon of the immediate early 1 gene was amplified. In order to exclude inhibitors of PCR amplification, a 268 bp fragment of the beta-globin gene was concurrently amplified in all samples. Viral cultures of blood and BAL were negative in all 23 non-immunocompromised, mechanically ventilated patients. Moreover, no CMV DNA could be amplified in blood BAL samples, whereas a beta-globin amplification was observed in all samples.
CONCLUSION: In a series of 23 critically ill patients under mechanical ventilation who were seropositive for CMV, no reactivation of CMV in blood or lung was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9120120      PMCID: PMC7094969          DOI: 10.1007/bf01709343

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  28 in total

1.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

2.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

3.  DNA nucleotide sequence heterogeneity between the Towne and AD169 strains of cytomegalovirus.

Authors:  R F Pritchett
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

4.  Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.

Authors:  G L Gilbert; K Hayes; I L Hudson; J James
Journal:  Lancet       Date:  1989-06-03       Impact factor: 79.321

5.  Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues.

Authors:  C B Toorkey; D R Carrigan
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

6.  Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique.

Authors:  H Einsele; M Steidle; A Vallbracht; J G Saal; G Ehninger; C A Müller
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

7.  Evaluation of human cytomegalovirus latency in alveolar macrophages.

Authors:  A Fajac; M Vidaud; F Lebargy; F Stephan; S Ricci; P Geslin; M Goossens; J F Bernaudin
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

8.  Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.

Authors:  R D Schrier; J A Nelson; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

Review 9.  Transfusion-associated cytomegalovirus infections.

Authors:  S P Adler
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

10.  Cytomegalovirus reactivation and tumour necrosis factor.

Authors:  W D Döcke; S Prösch; E Fietze; V Kimel; H Zuckermann; C Klug; U Syrbe; D H Krüger; R von Baehr; H D Volk
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

View more
  15 in total

Review 1.  Impact of cytomegalovirus load on host response to sepsis.

Authors:  Thomas Marandu; Michael Dombek; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402

Review 2.  CMV in critically ill patients: pathogen or bystander?

Authors:  Ajit P Limaye; Michael Boeckh
Journal:  Rev Med Virol       Date:  2010-11       Impact factor: 6.989

Review 3.  Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.

Authors:  Charles H Cook; Joanne Trgovcich
Journal:  Antiviral Res       Date:  2011-03-23       Impact factor: 5.970

4.  Cytomegalovirus in the intensive care unit: pathogen or passenger?

Authors:  Jeffrey I Cohen
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

5.  Broncholaveolar lavage to detect cytomegalovirus infection, latency, and reactivation in immune competent hosts.

Authors:  Sara Mansfield; Varun Dwivedi; Sara Byrd; Joanne Trgovcich; Marion Griessl; Michael Gutknecht; Charles H Cook
Journal:  J Med Virol       Date:  2016-02-02       Impact factor: 2.327

6.  Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia.

Authors:  Yannael Coisel; Sabri Bousbia; Jean-Marie Forel; Sami Hraiech; Bernard Lascola; Antoine Roch; Christine Zandotti; Matthieu Million; Samir Jaber; Didier Raoult; Laurent Papazian
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Active cytomegalovirus infection in patients with septic shock.

Authors:  Lutz von Müller; Anke Klemm; Manfred Weiss; Marion Schneider; Heide Suger-Wiedeck; Nilgün Durmus; Walter Hampl; Thomas Mertens
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

8.  A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients.

Authors:  Paula Lopez Roa; Maria Jesus Perez-Granda; Patricia Munoz; Pilar Catalan; Roberto Alonso; Eduardo Sanchez-Perez; Emma Novoa; Emilio Bouza
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 9.  Cytomegalovirus infection in critically ill patients: a systematic review.

Authors:  Ryosuke Osawa; Nina Singh
Journal:  Crit Care       Date:  2009-05-14       Impact factor: 9.097

10.  Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Nicholas J Cowley; Andrew Owen; Sarah C Shiels; Joanne Millar; Rebecca Woolley; Natalie Ives; Husam Osman; Paul Moss; Julian F Bion
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.